Quick Answer
Theriva Biologics, Inc. reported Total Assets of $38.24 million for fiscal year 2025.
Theriva Biologics, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $38.24M | +8.2% |
| 2024 | $35.35M | -36.0% |
| 2023 | $55.22M | -23.2% |
| 2022 | $71.86M | -6.8% |
| 2022 | $77.11M | -4.4% |
| 2022 | $80.64M | +14.6% |
| 2021 | $70.36M | +736.7% |
| 2020 | $8.41M | -51.2% |
| 2019 | $17.23M | -42.8% |
| 2018 | $30.14M | +60.0% |
| 2017 | $18.84M | -16.3% |
| 2016 | $22.50M | -27.1% |
| 2015 | $30.84M | +61.1% |
| 2014 | $19.14M | +17.8% |
| 2013 | $16.26M | +21.1% |
| 2012 | $13.42M | +79.5% |
| 2011 | $7.48M | +81.9% |
| 2010 | $4.11M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $30.84M | -23.1% | -13.9% |
| June 30, 2025 | $35.83M | -15.5% | +11.4% |
| March 31, 2025 | $32.16M | -34.0% | -9.0% |
| December 31, 2024 | $35.35M | -36.0% | -11.9% |
| September 30, 2024 | $40.11M | -34.8% | -5.4% |
| June 30, 2024 | $42.39M | -35.2% | -13.0% |
| March 31, 2024 | $48.73M | -28.2% | -11.8% |
| December 31, 2023 | $55.22M | -23.2% | -10.3% |
- Theriva Biologics, Inc. showed an increase of +8.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Theriva Biologics, Inc.’s total assets has grown by 830.2% (from $4.11 million to $38.24 million).
- The most recent figure is from Theriva Biologics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: